Skip to main content

Table 3 Multivariate logistic regression analysis for independent risk factors associated with CACS ≥300

From: Coronary artery calcium score plays an important role for cardiovascular risk stratification in the statin benefit groups of asymptomatic individuals

 

Moderate-intensity statin therapy group

High-intensity statin therapy group

Odds ratio

95% CI

p-value

Odds ratio

95% CI

p-value

Age

1.206

0.990–1.470

0.062

1.299

1.137–1.483

<0.001

Gender, male

6.726

0.149–302.635

0.326

44.252

1.959–999.784

0.017

Body mass index

0.834

0.491–1.415

0.501

1.095

0.735–1.632

0.655

Waist circumference

0.984

0.841–1.150

0.838

0.956

0.838–1.089

0.498

Systolic BP

1.015

0.901–1.144

0.801

1.066

0.999–1.138

0.053

Diastolic BP

1.027

0.884–1.194

0.723

0.988

0.889–1.097

0.816

Heart rate

0.969

0.901–1.097

0.906

0.958

0.895–1.025

0.215

Total cholesterol

1.010

0.850–1.105

0.635

1.056

0.978–1.139

0.164

Triglyceride

1.049

0.987–1.035

0.385

0.990

0.973–1.007

0.232

HDL-C

1.021

0.900–1.221

0.542

0.901

0.800–1.015

0.087

LDL-C

0.977

0.893–1.168

0.757

0.944

0.872–1.022

0.155

Fasting blood glucose

0.753

0.837–1.141

0.773

1.046

1.007–1.087

0.021

HbA1c

1.734

0.087–6.551

0.797

1.034

0.321–3.325

0.956

Fasting insulin

0.131

0.261–11.521

0.569

1.525

0.931–2.499

0.094

HOMA-IR

1.279

0.000–377.759

0.617

0.235

0.041–1.346

0.104

C reactive protein

0.879

0.809–2.024

0.292

0.249

0.008–8.009

0.432

Ten-year ASCVDS

0.948

0.386–1.999

0.758

0.967

0.831–1.127

0.669

  1. *Statin benefit group was defined as individuals who should be considered moderate- and high-intensity statin therapy
  2. CAC coronary artery calcium, CI confidence intervals, BP blood pressure, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment insulin resistance, ASCVD atherosclerotic cardiovascular disease
Back to article page

Lipids in Health and Disease

ISSN: 1476-511X